CDX2 and neoplasm: The CDX2-positive group showed two staining patterns: a score of 2 (moderate/strong staining in most tumor cells) was observed in 37.9% of patients (n = 66/174) (Panel C), and a score of 3 (strong staining in all tumor cells) was observed in 55.7% of patients (n = 97/174) (Panel D) (Figure 1b).